The immune system's involvement in obesity-driven type 2 diabetes

被引：134
|
作者：
Shu, Chengyi Jenny [1 ]
Benoist, Christophe [1 ]
Mathis, Diane [1 ]
机构：
[1] Harvard Univ, Div Immunol, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA
来源：
SEMINARS IN IMMUNOLOGY | 2012年 / 24卷 / 06期
关键词：
Obesity; Type; 2; diabetes; Inflammation; Adipose tissue; Insulin resistance; DIET-INDUCED OBESITY; REGULATORY T-CELLS; ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; B-CELLS; ALTERNATIVE ACTIVATION; NLRP3; INFLAMMASOME; UNIQUE POPULATION;
D O I：
10.1016/j.smim.2012.12.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Type 2 diabetes is now a worldwide epidemic, strongly correlated with an elevated incidence of obesity. Obesity-associated adipose tissue inflammation is a major cause of the decreased insulin sensitivity seen in type 2 diabetes. Recent studies have shed light on the cross-talk between the immune system and organismal metabolism. This review discusses the connection between inflammation in adipose tissue and systemic insulin resistance, focusing on the roles of innate and adaptive immune cell subsets in the pathogenesis of this metabolic disease. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：436 / 442
页数：7
相关论文
共 50 条
  • [1] The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study
    Davis, WA
    Knuiman, MW
    Hendrie, D
    Davis, TME
    INTERNAL MEDICINE JOURNAL, 2006, 36 (03) : 155 - 161
  • [2] Mechanisms and inhibition RIOK2 for obesity-driven prostate cancer
    Macias, Everardo
    Cho, Jiyoon
    Rosowicz, Drew
    Heidari, Zahra
    You, Sungyong
    Maravilla, Erick J.
    Chi, Jen-Tsan
    Freedland, Stephen J.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] A data-driven computational model for obesity-driven diabetes onset and remission through weight loss
    Yildirim, Vehpi
    Sheraton, Vivek M.
    Brands, Ruud
    Crielaard, Loes
    Quax, Rick
    van Riel, Natal A. W.
    Stronks, Karien
    Nicolaou, Mary
    Sloot, Peter M. A.
    ISCIENCE, 2023, 26 (11)
  • [4] The endocannabinoid system in obesity and type 2 diabetes
    V. Di Marzo
    Diabetologia, 2008, 51 : 1356 - 1367
  • [5] The endocannabinoid system in obesity and type 2 diabetes
    Di Marzo, V.
    DIABETOLOGIA, 2008, 51 (08) : 1356 - 1367
  • [6] A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes
    Ju Wang
    Agustin Casimiro-Garcia
    Bryce G. Johnson
    Jennifer Duffen
    Michael Cain
    Leigh Savary
    Stephen Wang
    Prashant Nambiar
    Matthew Lech
    Shanrong Zhao
    Li Xi
    Yutian Zhan
    Jennifer Olson
    James A. Stejskal
    Hank Lin
    Baohong Zhang
    Robert V. Martinez
    Katherine Masek-Hammerman
    Franklin J. Schlerman
    Ken Dower
    Scientific Reports, 13
  • [7] A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes
    Wang, Ju
    Casimiro-Garcia, Agustin
    Johnson, Bryce G.
    Duffen, Jennifer
    Cain, Michael
    Savary, Leigh
    Wang, Stephen
    Nambiar, Prashant
    Lech, Matthew
    Zhao, Shanrong
    Xi, Li
    Zhan, Yutian
    Olson, Jennifer
    Stejskal, James A.
    Lin, Hank
    Zhang, Baohong
    Martinez, Robert V.
    Masek-Hammerman, Katherine
    Schlerman, Franklin J.
    Dower, Ken
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] GIP's involvement in the pathophysiology of type 2 diabetes
    Christensen, Mikkel B.
    Gasbjerg, Laerke S.
    Heimbuerger, Sebastian M.
    Stensen, Signe
    Vilsboll, Tina
    Knop, Filip K.
    PEPTIDES, 2020, 125
  • [9] Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
    Creely, S. J.
    McTernan, P. G.
    Kusminski, C. M.
    Fisher, Ff. M.
    Da Silva, N. F.
    Khanolkar, M.
    Evans, M.
    Harte, A. L.
    Kumar, S.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E740 - E747
  • [10] PD-1 inhibitor treatment impacts both immune and metabolic pathways in obesity-driven endometrial cancer
    Staley, A.
    Tucker, K.
    Fang, Z.
    Sun, W.
    Yin, Y.
    Zhang, Y.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 48 - 48
12345